相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6
Andrew W. Chung et al.
NPJ BREAST CANCER (2022)
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches
Silvia Grassilli et al.
DIAGNOSTICS (2022)
Know thy cells: commonly used triple-negative human breast cancer cell lines carry mutations in RAS and effectors
Kay-Uwe Wagner
BREAST CANCER RESEARCH (2022)
FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis
Ying Song et al.
ONCOGENE (2021)
Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function
Kirsteen J. Campbell et al.
CELL DEATH AND DIFFERENTIATION (2021)
Targeting the Vav1/miR-29b axis as a potential approach for treating selected molecular subtypes of triple-negative breast cancer
Silvia Grassilli et al.
ONCOLOGY REPORTS (2021)
Molecular Pathogenesis and Regulation of the miR-29-3p-Family: Involvement of ITGA6 and ITGB1 in Intra-Hepatic Cholangiocarcinoma
Yuto Hozaka et al.
CANCERS (2021)
Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells
Penn Muluhngwi et al.
CANCERS (2021)
miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis
Dong Pan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells
Anna De Blasio et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin
Cristina Alexandra Ciocan-Cartita et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells
Cristina Alexandra Ciocan-Cartita et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3
Bao Zhang et al.
BIOLOGICAL RESEARCH (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A Looking-Glass of Non-Coding RNAs in Oral Cancer
Alexandra Iulia Irimie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies
Carsten Denkert et al.
LANCET (2017)
MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells
Hua Wang et al.
ONCOTARGET (2017)
The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells
Penn Muluhngwi et al.
SCIENTIFIC REPORTS (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
An overview of triple-negative breast cancer
Pankaj Kumar et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
Ioannis S. Vlachos et al.
NUCLEIC ACIDS RESEARCH (2015)
MiR-886-5p Inhibition Inhibits Growth and Induces Apoptosis of MCF7 Cells
Lei-Lei Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Molecular Pathways: microRNAs, Cancer Cells, and Microenvironment
Ioana Berindan-Neagoe et al.
CLINICAL CANCER RESEARCH (2014)
NCRNA Combined Therapy as Future Treatment Option for Cancer
Cornelia Braicu et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?
Roxana Chiorean et al.
BREAST (2013)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Hiroko Masuda et al.
CLINICAL CANCER RESEARCH (2013)
miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis
Adam J. Kole et al.
GENES & DEVELOPMENT (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
Yoon-La Choi et al.
BMC CANCER (2010)
MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
William C. S. Cho
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)